Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Safety Study of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Stage II Palliation of Hypoplastic Left Heart Syndrome

NCT01883076 is registered in ClinicalTrials.gov with Timothy J Nelson, MD, PhD as lead sponsor.

NCT NCT01883076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01883076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Safety Study of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Stage II Palliation of Hypoplastic Left Heart Syndrome
Lead sponsor
Timothy J Nelson, MD, PhD
Phase
Phase 1
Overall status
Completed
Start date
May 15, 2013
Completion date
April 28, 2021
Enrollment
30 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypoplastic left heart syndrome